The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Non-myeloablative allogeneic blood or marrow transplantation (AlloBMT) with post-transplant cyclophosphamide (PTCy) for peripheral T-cell lymphoma (PTCL): Improved outcomes with peripheral blood (PB) allografts and increased total body irradiation (TBI) to 400 cGV.
 
Cole Harris Sterling
No Relationships to Disclose
 
Michael Sang Hughes
No Relationships to Disclose
 
Hua-Ling Tsai
No Relationships to Disclose
 
Ephraim Joseph Fuchs
Employment - Iyuda Therapeutics
Stock and Other Ownership Interests - Iyuda Therapeutics
Consulting or Advisory Role - Abintus Bio; Allogene Therapeutics; Incysus; Jasper Therapeutics; Jazz Pharmaceuticals; Precision BioSciences; Talaris Therapeutics
Patents, Royalties, Other Intellectual Property - patents licensed to Iyuda Therapeutics LLC
 
Kathryn Yarkony
No Relationships to Disclose
 
Ravi Varadhan
No Relationships to Disclose
 
Douglas Edward Gladstone
No Relationships to Disclose
 
Lode J. Swinnen
Honoraria - Abbvie; Celgene; Pharmacyclics
Consulting or Advisory Role - Abbvie; Celgene; Pharmacyclics
Research Funding - Abbvie (Inst)
 
Richard J. Jones
No Relationships to Disclose
 
Nina D. Wagner-Johnston
Consulting or Advisory Role - Epizyme; Grunenthal; Karyopharm Therapeutics; Seagen
Research Funding - Acerta Pharma (Inst); ADC Therapeutics (Inst); Astex Pharmaceuticals (Inst); Genentech (Inst); Juno Therapeutics (Inst); Merck (Inst); Novartis/Pfizer (Inst); Regeneron (Inst)
 
Richard F. Ambinder
No Relationships to Disclose